Article
Public (all visitors)
Pharmaceuticals and innovation. Less buck for the bang. Are drug patents worth it?
The Economist
2021
Resources from The Economist
Politicians are attacking IP protection, but shareholders are Big Pharma’s bigger headache | Business
Comments
Keep exploring
Related resources
More to explore from shared collections and topics.
Contribute to BackpackerU Resources
Found something worth adding?
Sign in to suggest resources and start organizing your own travel-learning library.
No comments yet.